Latest news Latest news Latest news

Latest news

Portfolio

Brouwerij Martens acquires United Dutch Breweries with a purpose of further joint global expansion

16/10/2024 - 07:45

Portfolio

Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease

15/10/2024 - 11:55

Portfolio

Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)

19/09/2024 - 17:45

Portfolio

ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment

18/09/2024 - 11:38

Portfolio

ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base

17/09/2024 - 17:01

Portfolio

Biotalys granted patents for EVOCA in both Europe and the US

17/09/2024 - 07:00

Portfolio

Gimv sells stake in Mega International to Bizzdesign, establishing a strong leadership position in the Enterprise Architecture and Digital Transformation space

05/09/2024 - 07:30

Corporate

Trading update

03/09/2024 - 07:00

Portfolio

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

02/09/2024 - 09:12

Portfolio

ImCheck Awarded EUR 20.18 Million from the French Government Through the France 2030 Investment and Innovation Plan

29/08/2024 - 14:10

Portfolio

Biotalys Named Sustainable Crop Protection Company of the Year

21/08/2024 - 09:31

Portfolio

Industry expert Roland Türk begins as new CEO of Techinfra GmbH

02/08/2024 - 13:46

Contact information

Investor Relations Investor Relations Investor Relations

Investor Relations

Do you have any questions or require more information? Please contact us.